A questionnaire-based study on knowledge and attitude towards counterfeit medication among the doctors in tertiary care hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20181190Keywords:
Counterfeit drug, Doctors, MedicationAbstract
Background: Counterfeit drugs are a global problem and suffered almost all developing and developed countries worldwide. In India, it is a major problem which results life threatening issues as well as financial loss on health system. So, we conducted a cross sectional questionnaire-based study on knowledge and exposure to counterfeit drugs of doctors at SHKM Govt. Medical College, Nuh, Haryana, India.
Methods: A structured questionnaire was distributed to 100 registered doctors. The questionnaire was based on knowledge, attitude and its consequence on the heath system by the practices of counterfeit medication.
Results: There were Twenty questionnaires excluded from the study due to incomplete information. Only 57.77% (46/80) subjects having the knowledge of questionnaire correct meaning of counterfeit drug. However, almost 90% (72/80) subjects were aware about its dangerous effects. More than 50% of the subjects have suggested that modern technology is capable to control counterfeiting of the medicine.
Conclusions: Counterfeit drugs create a people health hazard and waste to consumer income. The proper knowledge, awareness and modern technological approaches are the devices may helpful in diminution of counterfeit medication practices.
References
Geneva, Switzerland: Department of Essential Drugs and Other Medicines, WHO; 1999. World Health Organization. Counterfeit Drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs. Available at: http://whqlibdoc.who.int/hq/1999/WHO_EDM_QSM99.1.pdf .
World Health Organization. General Information on Counterfeit Medicines. [Last accessed on 2013 May 19]. Available at: http://www.who.int/medicines/services/counterfeit/overview/en
Counterfeit Drugs Kill, World Health Organization. Available at: http://www.who.int/impact/FinalBrochureWHA2008a.pdf
Bate R. Washington DC. American Enterprise Institute. Making a killing. The deadly implications of the counterfeit drug trade; 2008.
Sammons HM, Choonara I. Substandard medicines: a greater problem than counterfeit medicines? BMJ Paediatrics Open. 2017;1:e000007.
Shah NA, Bhagya M, Sattigeri, Nirav NP, Haresh AD. Counterfeit drugs in India: significance and impact on pharmacovigilance. Int J Res Med Sci. 2015;3:2156-60.
Chika FU, Alphonsus CO, Obiageli FE, Maureen NA, Andrew UU, Samuel OI. Factors associated with drug counterfeit in Nigeria: A twelve-year review. British Journal of Medicine & Medical Research. 2016;12:1-8.
Golocorbin KS, Mikov M. Counterfeit drugs as a gobal threat to health. Med Pregl. 2011;64:285-90.
Nagaraj A, Tambi S, Biswas G, Ganta S, Kumawat H, Mathur G. Counterfeit medication: Perception of doctors and medical wholesale distributors in western India. J Int Soc Prev Community Dent. 2015;5:S7-S11.
Mackey TK, Cuomo R, Guerra C, Liang BA. After counterfeit Avastin®--what have we learned and what can be done? Nat. Rev Clin Oncol. 2015;12(5):302-08.
Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm. Sci. 2011;100:4571-79.
Bansal D, Malla S, Gudala K, Tiwari P. Anti-counterfeit technologies: a pharmaceutical industry perspective. Sci Pharm. 2013;81:1-13.
Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: asystematic review of the literature. BMJ Open. 2013;3;1-7.
